Cost-effectiveness of interferon alfa 2b
β
W. Ray Kim; John J. Poterucha
π
Article
π
2000
π
John Wiley and Sons
π
English
β 34 KB
π 2 views
In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th